Suchergebnisse - "Potter, David"

PubPharm (359)

1

Impact of body mass index on pathological response after neoadjuvant chemotherapy : results from the I-SPY 2 trial

enthalten in: Breast cancer research and treatment | 2024

von Wang, H. | Yee, D. | Potter, D. | +10

UpdateOf: Res Sq. 2023 May 31;:. - PMID 37397981

2

Translation of nonclinical to clinical safety findings for 27 biotherapeutics

enthalten in: Toxicology and applied pharmacology | 2024

von Leach, M. | Rana, P. | Hu, W. | +8

3

CUBANYL BIGUANIDE COMPOUNDS

enthalten in: Europäisches Patentamt | 2024

von POTTER DAVID A | GUO ZHIJUN | GEORG GUNDA | +4

4

Cooling inflammation while potentiating immune checkpoint inhibition : Enhancing the benefit-risk ratio of immuno-oncology therapy

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2024

von Potter, D. | Guo, Z. | Lei, J. | +1

CommentOn: Proc Natl Acad Sci U S A. 2024 Feb 13;121(7):e2314085121. - PMID 38330013

5

Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Albain, K. | Yau, C. | Petricoin, E. | +46

6

Development of an International Virtual Multidisciplinary Tumor Board for Breast Cancer in Mongolia

enthalten in: The Journal of surgical research | 2024

von Brownson, K. | Flores-Huidobro Martinez, A. | Ganbayar, J. | +10

7

Impact of body mass index on pathological response after neoadjuvant chemotherapy: results from the I-SPY 2 trial

enthalten in: Breast cancer research and treatment | 2024

von Wang, H. | Yee, D. | Potter, D. | +9

8

ANTI-CERULOPLASMIN ANTIBODIES AND USES THEREOF

enthalten in: Europäisches Patentamt | 2023

von POTTER DAVID GEORGE | DZIELAWA JENNIFER ANN | CARTER BRENDA SUE | +1

9

Impact of Body Mass Index on Pathological Response after Neoadjuvant Chemotherapy : Results from the I-SPY 2 trial

enthalten in: Research square | 2023

von Wang, H. | Yee, D. | Potter, D. | +9

UpdateIn: Breast Cancer Res Treat. 2024 Jan 12;:. - PMID 38216819

10

Endothelial Dysfunction in Breast Cancer Survivors on Aromatase Inhibitors : Changes over Time

enthalten in: Research square | 2023

von Shaaban, A. | Petersen, A. | Beckwith, H. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[36]